Effects on plasma endotoxin and eicosanoid concentrations and serum cytokine activities in horses competing in a 48-, 83-, or 159-km endurance ride under similar terrain and weather conditions

American Journal of Veterinary Research

Volumn 64, Issue 6, 2003, Pages 754-761

  Barton, Michelle H ^a   Williamson, Lisa ^a   Jacks, Stephanie ^a,b   Norton, Natalie ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CALCIUM; CREATINE KINASE; CYTOKINE; ELECTROLYTE; ENDOTOXIN; ENDOTOXIN ANTIBODY; ICOSANOID; INTERLEUKIN 6; LACTIC ACID; PLASMA PROTEIN; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL WELLBEING; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY WEIGHT; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; ENDOTOXEMIA; ENDOTOXIN DETECTION; ENZYME ACTIVITY; EXERCISE; FATTY ACID BLOOD LEVEL; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HORSE; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; NONHUMAN; PHYSICAL PARAMETERS; PHYSICAL STRESS; PROTEIN BLOOD LEVEL; RECTUM TEMPERATURE; SPORT; TEMPERATURE MEASUREMENT; TOPOGRAPHY; WEATHER;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CYTOKINES; EICOSANOIDS; ENDOTOXINS; EXERTION; FEMALE; HORSES; MALE; PHYSICAL CONDITIONING, ANIMAL; WEATHER;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0037501031     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.754     Document Type: Article

References (36)

1. MacKay R. Endotoxemia. In: Smith B, ed. Large animal internal medicine. St Louis: Mosby Year Book Inc, 1996;733-742.
2. Cargile JL, MacKay RF, Dankert JR, et al. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin. Am J Vet Res 1995;56:1451-1459.
3. Carrick J, Morris D, Moore J. Administration of a receptor antagonist for platelet activating factor during equine endotoxemia. Equine Vet J 1993;25:152-157.
4. Henry M, Moore J. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes. Circ Shock 1988;26:297-309.
5. Morris DD, Moore JN, Crowe N. Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am J Vet Res 1991;52:1565-1569.
6. Morris DD, Moore JN, Crowe N, et al. Effect of experimentally induced endotoxemia on serum interleukin-6 activity in horses. Am J Vet Res 1992;53:753-756.
7. Semrad S, Hardee G, Hardee M, et al. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxemia in horses. Equine Vet J 1987;19:201-203.
8. Camus G, Deby-DuPont G, Duchateau J, et al. Are similar inflammatory factors involved in strenuous exercise and sepsis? Intensive Care Med 1994;20:602-610.
9. Cooper K. Some responses of the cardiovascular system to heat and fever. Can J Cardiol 1994;10:444-448.
10. Hines M, Schott H, Bayly W, et al. Exercise and immunity: a review with emphasis on the horse. J Vet Intern Med 1996;10:280-289.
11. Bosenberg A, Brock-Utne T, Gaffin S. Strenuous exercise causes systemic endotoxemia. J Appl Physiol 1988;65:106-108.
12. Brock-Utne J, Gaffin S, Wells T, et al. Endotoxaemia in exhausted runners after a long-distance race. S Afr Med J 1988;73:533-536.
13. Morrison D, Ryan J. Endotoxins and disease mechanisms. Ann Rev Med 1987;320:365-376.
14. King J, Gerring E. Detection of endotoxin in cases of equine colic. Vet Rec 1988;123:269-271.
15. Moore J, White N, Trim C, et al. Endotoxemia following experimental intestinal strangulation obstruction in ponies. Can J Comp Med 1981;45:330-332.
16. Gathiram P, Wells M, Raidoo D, et al. Portal and systemic plasma lipopolysaccharide concentrations in heat-stressed primates. Circ Shock 1988;25:223-230.
17. Baker B, Gaffin S, Wells M, et al. Endotoxaemia in race-horses following exertion. J S Afr Vet Assoc 1988;59:63-66.
18. Barton M, Williamson L, Jacks S, et al. Body weight, hematologic findings, and serum and plasma biochemical findings of horses competing in a 48-, 83-, or 159-km endurance ride under similar terrain and weather conditions. Am J Vet Res 2003;64:746-753.
19. Henry MM, Moore JN. Clinical relevance of monocyte procoagulant activity in horses with colic. J Am Vet Med Assoc 1991;198:843-848.
20. Camus G, Poortmans J, Nys M, et al. Mild endotoxaemia and the inflammatory response induced by a marathon race. Clin Sci 1997;92:415-422.
21. Moore G, Blair Holbein M, Knochel J. Exercise-associated collapse in cyclists is unrelated to endotoxemia. Med Sci Sports Exerc 1995;27:1238-1242.
22. Alanka J, Riutta A, Vappatalo H. Effects of catecholamines on eicosanoid synthesis with special reference to prostanoid/leukotriene ratio. Free Radic Biol Med 1992;13:677-688.
23. Hinchcliff K, McKeever K, Muir W. Effect of phenylbutazone on the haemodynamic, acid-base, and eicosanoid responses of horses to sustained submaximal exertion. Res Vet Sci 1994;56:353-362.
24. Johansson I, Kallings P, Hammarlund-Udenaes M. Studies of meclofenamic acid and two metabolites in horses-pharmacokinetics and effects on exercise tolerance. J Vet Pharmacol Ther 1991; 14:235-242.
25. Mitten LA, Hinchcliff KW, Pate JL, et al. Effect of exercise intensity on plasma prostaglandin concentrations in horses. Am J Vet Res 1995;56:122-126.
26. Mitten LA, Hinchcliff KW, Pate JL. Phenylbutazone increases right atrial pressure and heart rate of running horses. J Appl Physiol 1996;81:312-317.
27. Ronni-Sivula H, Malm H, Ylikorkala O, et al. Marathon run stimulates more prostacyclin than thromboxane synthesis and differently in men and women. Prostaglandins 1993;46:75-79.
28. Ohnishi A, Ishnizaki T, Echizen H, et al. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans. Clin Pharmacol Ther 1992;51:454-464.
29. Chen H, Chang W. Effects of exercise training on the biosynthesis of prostacyclin and thromboxane in rats. Acta Physiol Scand 1993;147:109-115.
30. Smith J, Teleford R, Baker M, et al. Cytokine immunoreactivity in plasma does not change after moderate endurance exercise. Int J Sports Med 1992;11:179-187.
31. Weinstock C, Konig D, Harnischmacher R, et al. Effect of exhaustive exercise on the cytokine response. Med Sci Sports Exerc 1997;29:345-354.
32. Northoff H, Weinstock C, Berg A. The cytokine response to strenuous exercise. Int J Sports Med 1994;15:S167-S171.
33. Ostrowski K, Rohde T, Asp S, et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999;515:287-291.
34. Camus G, Nys M, Poortmans J, et al. Endotoxaemia, production of tumor necrosis factor alpha and polymorphonuclear activation following strenuous exercise in humans. Eur J Appl Physiol 1998; 79:62-68.
35. Papanicolaou DA, Petrides JS, Tsigos C, et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996;271: E601-E605.
36. Derijk R, Mitchelson D, Karp B, et al. Exercise and circadian rhythm-induced variations in plasma corticol differentially regulate interleukin 1, IL-6, and tumor necrosis factor alpha production in humans: high sensitivity of TNF and resistance of IL-6. J Clin Endocrinol Metab 1997;82:2181-2191.